# A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas

> **NCT01838317** · PHASE2 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 14 (actual)

## Conditions studied

- Cancer of the Pancreas

## Interventions

- **DRUG:** Pioglitazone

## Key facts

- **NCT ID:** NCT01838317
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2017-09-20
- **Final completion:** 2017-09-20
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2021-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01838317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01838317, "A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01838317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*